Literature DB >> 3702483

Increased production of peroxidation products associated with cardiac operations. Evidence for free radical generation.

D Royston, J S Fleming, J B Desai, S Westaby, K M Taylor.   

Abstract

We investigated the degree and time course of neutrophil sequestration into human lungs during cardiac operations. At the same time, measurement of the concentration of peroxidation products in the plasma was used as an index of oxidant free radical activity. The study was performed in two groups of patients. Group A (n = 11) had studies extending over the entire operative period and showed a highly significant sequestration of neutrophils into the lung, together with a highly significant (p less than 0.001) rise in peroxidation products from 2.8 +/- 0.12 nmol/ml(mean +/- standard error of the mean)before bypass to a peak of 5.05 +/- 0.13 nmol/ml at the end of bypass. As these changes occurred only during the time after release of the aortic cross-clamp, we investigated this period in more detail in a second group of patients (Group B, n = 7). Results from this group showed that significant release of peroxidation products occurred at the same time as pulmonary neutrophil sequestration. This study has produced evidence of increased oxidant activity in the lung associated with cardiac operations. Nevertheless, it is not known whether the neutrophils sequestered into the lung alone induced the increased activity. Similarly, whether neutrophil-derived oxidant species are the sole cause of lung tissue injury remains unproved.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702483

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

Review 1.  Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.

Authors:  S Westaby
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

2.  Extracorporeal membrane oxygenation induced cardiac dysfunction in newborn lambs.

Authors:  Lee A Pyles; Robert A Gustafson; James Fortney; Stanley Einzig
Journal:  J Cardiovasc Transl Res       Date:  2010-09-17       Impact factor: 4.132

3.  Determination of ethane and pentane in free oxygen radical-induced lipid peroxidation.

Authors:  O M Pitkänen; M Hallman; S M Andersson
Journal:  Lipids       Date:  1989-02       Impact factor: 1.880

4.  Complement conversion and leukocyte kinetics in open heart surgery.

Authors:  J Utoh; T Yamamoto; T Kambara; H Goto; Y Miyauchi
Journal:  Jpn J Surg       Date:  1988-05

5.  Shock-reinfusion injury to the central organs and the effect of free radical scavengers in the rat.

Authors:  K Hamano; H Tsuboi; A Seyama; K Esato
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

6.  Oxygen consumption after cardiopulmonary bypass--implications of different measuring methods.

Authors:  H M Oudemans-van Straaten; G J Scheffer; L Eysman; C R Wildevuur
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.

Authors:  G Ambrosio; A Oriente; C Napoli; G Palumbo; P Chiariello; G Marone; M Condorelli; M Chiariello; M Triggiani
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 8.  Could treatment with scavengers of oxygen free radicals minimize complications in cardiac surgery?

Authors:  J Vaage; G Valen
Journal:  Klin Wochenschr       Date:  1991-12-15

9.  Prolonged granulocyte activation, as well as hypoxanthine and free radical production after open heart surgery in children.

Authors:  E J Pesonen; R Korpela; M Leijala; H Sairanen; O M Pitkänen; K O Raivio; P Venge; S Andersson
Journal:  Intensive Care Med       Date:  1996-05       Impact factor: 17.440

10.  Effects of cardiopulmonary bypass on pulmonary function in COPD patients undergoing beating heart coronary artery bypass surgery.

Authors:  Erdem Çetin; Levent Altinay
Journal:  Cardiovasc J Afr       Date:  2019-05-24       Impact factor: 1.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.